### 18601 Federal Register / Vol. 78, No. 59 / Wednesday, March 27, 2013 / Notices

For Form 2: Antimicrobial Susceptibility Testing, the annual frequency of responses per respondent is 1,452 (121 isolates × 12 months). Based on previous laboratory experience, the estimated burden of completing Form 2 for each participating laboratory is 1 hour per response, which includes the time required for laboratory processing of the patient’s isolate, gathering and maintaining the data needed, and completing and reviewing the collection of information. For Form 3: Control Strain Susceptibility Testing, a ‘‘response’’ is defined as the processing and recording of Regional laboratory data for a set of seven control strains. It takes approximately 12 minutes to process and record the Regional laboratory data on Form 3 for one set of seven control strains, of which there are 4 sets. The number of responses per respondent is 48 (4 sets × 12 months). There are no additional costs to respondents.



### E STIMATE OF 

### A NNUALIZED 

### B URDEN 

### H OURS

Type of respondent Form name Number of respondents Number of responses per

respondent Avg. burden per response

(in hours) Total annual burden (in hours)

Clinic .............................. Demographic Clinical Data Form 1 ..................... 30 240 11/60 1,320 Laboratory ...................... Antimicrobial Susceptibility Testing Form 2 ........ 5 1,452 1 7,260 Control Strain Susceptibility Testing Form 3 ....... 5 48 12/60 48

Total ........................ .............................................................................. 40 ................. ....... ........................ 8,628

Dated: March 21, 2013. Ron A. Otten, Director, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2013–07059 Filed 3–26–13; 8:45 am]

**BILLING CODE 4163–18–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**Advisory Committee on Breast Cancer in Young Women (ACBCYW)** 

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee:

Time and Date: 9:00 a.m.–11:00 a.m. EDT, April 16, 2013.

Place: The meeting will be held via teleconference.

Teleconference login information is as follows: For Public:

TOLL–FREE PHONE #: 800–857–4875 Participant passcode: 9377 Net Conference URL: https:// www.mymeetings.com/nc/join/

Conference number: PW8921926 Audience passcode: 9377 or Public can join the event directly: https:// www.mymeetings.com/nc/ join.php?i=PW8921926&p=9377&t=c

There is also a toll number for anyone outside of the USA:

TOLL #: 1–212–287–1661 Participant passcode: 9377 Please go to the ACBCYW meeting Web page to register for this meeting: http://www.cdc.gov/cancer/breast/ what

_ cdc

_is

_ doing/conference.htm. Status: Open to the public, limited only by the number of phone lines available.

Purpose: The committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and dissemination of credible appropriate messages and resource materials.

Matters To Be Discussed: The agenda will include discussions on approaches to increase awareness of clinicians/ practitioners regarding topics such as breast health, symptoms, diagnosis, and treatment of breast cancer in young women; and information needs and delivery mechanisms for women at higher risks for developing breast cancer. These discussions will be directed toward the final review and approval of formal recommendations on these topics.

Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Temeika L. Fairley, Ph.D., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway NE., Mailstop K52, Atlanta, Georgia, 30341, Telephone (770) 488–4518, Fax (770) 488–4760, Email: acbcyw@cdc.gov.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and Agency for Toxic Substances and Disease Registry.

Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2013–06946 Filed 3–26–13; 8:45 am]

**BILLING CODE 4163–18–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**Respirator Certification Fees; Public Meeting** 

**AGENCY :**  The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

**ACTION :**  Notice of public meeting.

**SUMMARY :**  The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) announces a public meeting. The purpose of this meeting is to allow stakeholders to present information the impact of an increase on respirator fees on individual respirator manufacturers, the respirator market, or on those industries that rely on NIOSH approved respiratory equipment.

**DATES :**  April 30, 2013, 10 a.m. to 4 p.m. EDT, or after the last public commenter has spoken, whichever occurs first.

**ADDRESSES :**  U.S. Office of Surface Mining, Three Parkway Center


### 18602 Federal Register / Vol. 78, No. 59 / Wednesday, March 27, 2013 / Notices

(Greentree), Pittsburgh, PA 15220. This meeting will also be available by remote access. Registration information is available on the NIOSH Web site at http://www.cdc.gov/niosh.

**FOR FURTHER INFORMATION CONTACT :**  David Book, NIOSH National Personal Protective Technology Laboratory (NPPTL), 626 Cochrans Mill Road, Pittsburgh, PA 15236 (412) 386–6691 or (412) 386–5200 (these are not toll free numbers).

**SUPPLEMENTARY INFORMATION :**  Public Meeting

NIOSH will hold a public meeting to allow commenters to present information on an increase in respirator certification and approval fees on individual respirator manufacturers, the respirator market, or on those industries that rely on NIOSH approved respiratory equipment.

Requests to make presentations at the public meeting should be mailed to the NIOSH Docket Office, Robert A. Taft Laboratories, MS–C34, 4676 Columbia Parkway, Cincinnati, OH 45226. Requests may also be submitted by telephone (513) 533–8611, facsimile (513) 533–8285, or emailed to nioshdocket@cdc.gov with the words ‘‘respirator fees presentation’’ in the subject line. All requests to present should contain the name, address, telephone number and relevant business affiliations of the presenter, and the approximate time requested for the presentation. Oral presentations will be limited to 15 minutes. After reviewing the requests for presentations, NIOSH will notify the presenter that his/her presentation is scheduled. If a participant is not in attendance when his/her presentation is scheduled to begin, the remaining participants will be heard in order. After the last scheduled speaker is heard, participants who missed their assigned times may be allowed to speak, limited by time available.

Attendees who wish to speak but did not submit a request for the opportunity to make a presentation may be given this opportunity after the scheduled speakers are heard, at the discretion of the presiding officer and limited by time available. This meeting will also be using audio/LiveMeeting Conferencing, remote access capabilities where interested parties may listen in and view the presentations over the Internet simultaneously. Parties remotely accessing the meeting will have the opportunity to comment during the open comment period.

Registration is required for both inperson and LiveMeeting participation. Because this meeting is being held at a Federal site, pre-registration is required on or before April 26, 2013 and a government-issued photo ID (driver’s license or passport) will be required to obtain entrance to the facility. Non-US citizens need to register by March 29, to allow sufficient time for mandatory facility security clearance procedures to be completed.

An email confirming registration will be sent from NIOSH for both in-person participation and audio conferencing participation. Details required to participate via the conferencing will be provided by NIOSH in a separate email. This option will be available to participants on a first come, first served basis and is limited to the first 100 participants.

Registration information is available on the NIOSH Web site at http:// www.cdc.gov/niosh.

Dated: March 20, 2013. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.
[FR Doc. 2013–06850 Filed 3–26–13; 8:45 am]

**BILLING CODE 4163–19–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**Advisory Committee to the Director (ACD), Centers for Disease Control and**  **Prevention (CDC)**

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee.

Time and Date: 8:30 a.m.–3:00 p.m. (EDT), April 25, 2013.

Place: CDC, Building 21, Rooms 1204 A/B, 1600 Clifton Road, NE., Atlanta, Georgia 30333.

Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 50 people. The public is welcome to participate during the public comment period, which is tentatively scheduled from 2:45 p.m. to 2:50 p.m. This meeting is also available by teleconference. Please dial (877) 930– 8819 and enter code 1579739.

Purpose: The committee will provide advice to the CDC Director on strategic and other broad issues facing CDC.

Matters To Be Discussed: The Advisory Committee to the Director will receive updates from the Global Workgroup; State, Tribal, Local and Territorial Workgroup; the Communications Workgroup; the Ethics Subcommittee, and the Health Disparities Subcommittee, as well as an update from the CDC Director.

Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Carmen Villar, M.S.W., Designated Federal Officer, Advisory Committee to the Director, CDC, 1600 Clifton Road NE., M/S D–14, Atlanta, Georgia 30333. Telephone 404/639–7000, Email: GHickman@cdc.gov. The deadline for notification of attendance is April 22, 2013. To register for this meeting, please send an email to ACDirector@cdc.gov

.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).
[FR Doc. 2013–06947 Filed 3–26–13; 8:45 am]

**BILLING CODE 4163–18–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Administration for Children and Families** 

**[CFDA Number: 93.676]**

**Announcement of the Award of Fifteen Single-Source Program Expansion**  **Supplement Grants to Unaccompanied Alien Children’s Shelter Care Grantees** 

**AGENCY :**  Office of Refugee Resettlement, Administration for Children and Families, Department of Health and Human Services.

**ACTION :**  Announcement of the award of fifteen single-source program expansion grants to ten current grantees to expand bed capacity and supportive services to the increasing number of unaccompanied alien children.

**SUMMARY :**  The Administration for Children and Families (ACF), Office of Refugee Resettlement (ORR) announces the award of fifteen single-source program expansion supplement grants to the following ten current grantees, for a total of $47,168,490.